First Trust Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-28,191
Closed -$2.03M 2507
2020
Q4
$2.03M Sell
28,191
-5,088
-15% -$266K ﹤0.01% 1570
2020
Q3
$1.52M Buy
33,279
+7,366
+28% +$308K ﹤0.01% 1523
2020
Q2
$1.17M Buy
25,913
+4,818
+23% +$216K ﹤0.01% 1662
2020
Q1
$812K Buy
+21,095
New +$971K ﹤0.01% 1735
2019
Q4
Sell
-7,732
Closed -$315K 2524
2019
Q3
$315K Sell
7,732
-36,933
-83% -$1.59M ﹤0.01% 2273
2019
Q2
$2.15M Sell
44,665
-15,299
-26% -$804K ﹤0.01% 1510
2019
Q1
$3.75M Sell
59,964
-14,910
-20% -$1.02M 0.01% 1184
2018
Q4
$4.47M Sell
74,874
-46,993
-39% -$2.82M 0.01% 1021
2018
Q3
$7.85M Buy
121,867
+59,845
+96% +$3.34M 0.01% 914
2018
Q2
$2.79M Buy
62,022
+42,901
+224% +$1.71M 0.01% 1438
2018
Q1
$594K Sell
19,121
-22,070
-54% -$726K ﹤0.01% 1980
2017
Q4
$1.23M Buy
+41,191
New +$1.19M ﹤0.01% 1768

Other funds holding BEAT

First Trust Advisors's BEAT Position: Q1 2021 in Review

First Trust Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 28,191 shares — an estimated $2.03M sold.

First Trust Advisors first reported a position in BEAT in Q4 2017 and held it in 12 quarters. The position peaked at $7.85M in Q3 2018. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • First Trust Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • First Trust Advisors sold 28,191 BioTelemetry, Inc. shares in Q1 2021, an estimated $2.03M.
  • First Trust Advisors first reported a position in BioTelemetry, Inc. in Q4 2017 and held it in 12 quarters.
  • First Trust Advisors's BioTelemetry, Inc. position peaked at $7.85M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on First Trust Advisors's 13F filing for Q1 2021, filed 14 May 2021.